NCT02297958View on ClinicalTrials.gov

Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

January 15, 2015

Primary Completion Date

July 27, 2019

Study Completion Date

July 27, 2019

Conditions
Ovarian Carcinoma
Trial Locations (1)

Unknown

Service de Gynécologie, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT02297958 - Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma | Biotech Hunter | Biotech Hunter